Literature DB >> 26014893

Industry Collaboration and Primary Guest Authorship of High-Impact Clinical Trials.

Nitin Roper1, Deborah Korenstein2.   

Abstract

Mesh：

Year:  2016        PMID： 26014893      PMCID： PMC4700019          DOI： 10.1007/s11606-015-3402-7

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  4 in total

1.  Prevalence of honorary and ghost authorship in Cochrane reviews.

Authors:  Graham Mowatt; Liz Shirran; Jeremy M Grimshaw; Drummond Rennie; Annette Flanagin; Veronica Yank; Graeme MacLennan; Peter C Gøtzsche; Lisa A Bero
Journal:  JAMA       Date:  2002-06-05       Impact factor: 56.272

2.  Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation.

Authors:  Joseph S Ross; Kevin P Hill; David S Egilman; Harlan M Krumholz
Journal:  JAMA       Date:  2008-04-16       Impact factor: 56.272

3.  Prevalence of articles with honorary authors and ghost authors in peer-reviewed medical journals.

Authors:  A Flanagin; L A Carey; P B Fontanarosa; S G Phillips; B P Pace; G D Lundberg; D Rennie
Journal:  JAMA       Date:  1998-07-15       Impact factor: 56.272

4.  Honorary and ghost authorship in high impact biomedical journals: a cross sectional survey.

Authors:  Joseph S Wislar; Annette Flanagin; Phil B Fontanarosa; Catherine D Deangelis
Journal:  BMJ       Date:  2011-10-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.